I read this on another site - Dr Lee seems to think its very promising and they are planning to going through FDA trials apparently - does anyone have any more info on this? I went to their website and it looks very encouraging!
http://www.androscience.com
They are a group of novel anti-androgens being investigated by the Androscience Corporation in San Diego. ASCJ products have the potential of being safe and very effective topical medications for defeating the action of DHT in the scalp. ASCJ is synthesized from a natural product and promotes the degradation of endogenous androgen receptors. This pharmacological mechanism differs completely from all currently available anti-androgens. In laboratory tests, topically applied testosterone induced inhibition of the hair cycle progression with prolongation of the telogen phase 50% of the time in the mouse model. Whereas anagen conversion was achieved in 100% of the mice given testosterone followed with ASCJ-9. The researchers concluded, “These preliminary observations suggest that ASCJ-9 is a potential candidate for effective and safe topical treatment of acne and male pattern baldness.â€*
Currently, AndroScience is conducting GLP (Good Laboratory Practice) toxicology and accumulating other preclinical data in order to file an IND (Investigational New Drug application) and proceed to Phase I and II clinical studies.
*Ching-Yuan Su “Effects of a Novel Anti-androgen on Rodent Models of Acne and Testosterone – Dependent Suppression of Hair Cycle†presented at the summer session of the American Academy of Dermatology 2005
Richard Lee, M.D.
Regrowth, LLC
http://www.androscience.com
They are a group of novel anti-androgens being investigated by the Androscience Corporation in San Diego. ASCJ products have the potential of being safe and very effective topical medications for defeating the action of DHT in the scalp. ASCJ is synthesized from a natural product and promotes the degradation of endogenous androgen receptors. This pharmacological mechanism differs completely from all currently available anti-androgens. In laboratory tests, topically applied testosterone induced inhibition of the hair cycle progression with prolongation of the telogen phase 50% of the time in the mouse model. Whereas anagen conversion was achieved in 100% of the mice given testosterone followed with ASCJ-9. The researchers concluded, “These preliminary observations suggest that ASCJ-9 is a potential candidate for effective and safe topical treatment of acne and male pattern baldness.â€*
Currently, AndroScience is conducting GLP (Good Laboratory Practice) toxicology and accumulating other preclinical data in order to file an IND (Investigational New Drug application) and proceed to Phase I and II clinical studies.
*Ching-Yuan Su “Effects of a Novel Anti-androgen on Rodent Models of Acne and Testosterone – Dependent Suppression of Hair Cycle†presented at the summer session of the American Academy of Dermatology 2005
Richard Lee, M.D.
Regrowth, LLC